Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Clinical trial NCT07453602 · RECRUITING

Trial details

NCT number: NCT07453602
Sponsor: Arcutis Biotherapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)Eczema

Start date: 2026-03-02
Primary completion: 2028-04-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.